Preclinical Technical Focus
AGADA's Cofounder, Dr. Nagaraju helped establish internationally accepted standard operating procedures (SOPs) for efficacy testing in neuromuscular disease models.
AGADA was founded to meet the growing needs for pre-clinical efficacy studies both as a key step in Sponsors de-risking their programs, and also for supporting orphan drug designation (FDA, EMA).
AGADA's leadership will work with your team on developing a robust experimental design and then carryout the study in a rigorous QA/QC environment.
We are effective, responsive communicators who will provide your team with timely feedback and reporting.
AGADA was founded to meet the growing needs for pre-clinical efficacy studies both as a key step in Sponsors de-risking their programs, and also for supporting orphan drug designation (FDA, EMA).
AGADA's leadership will work with your team on developing a robust experimental design and then carryout the study in a rigorous QA/QC environment.
We are effective, responsive communicators who will provide your team with timely feedback and reporting.
